Dela Cerna, Sam Jade S.
HRN: 18-31-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CEFUROXIME 750MG (VIAL)
05/22/2022
05/29/2022
IV
750
Q8hours
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes